Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Deyde, Varough M ^a   Sampath, Rangarajan ^b   Garten, Rebecca J ^a   Blair, Patrick J ^c   Myers, Christopher A ^c   Massire, Christian ^b   Matthews, Heather ^b   Svoboda, Pavel ^d   Reed, Matthew S ^d   Pohl, Jan ^d   Klimov, Alexander I ^a   Gubareva, Larisa V ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b Ibis Biosciences   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE DERIVATIVE; LIVE VACCINE; OSELTAMIVIR;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA BASE COMPOSITION; ELECTROSPRAY MASS SPECTROMETRY; GENETIC IDENTIFICATION; GENETIC REASSORTMENT; GENETIC VARIABILITY; GENOME IMPRINTING; HIGH THROUGHPUT SCREENING; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS IDENTIFICATION; GENETICS; HUMAN; INFLUENZA; ISOLATION AND PURIFICATION; LIMIT OF DETECTION; METHODOLOGY; SEASON; VIROLOGY;

AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LIMIT OF DETECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEASONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 78149436184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013293     Document Type: Article

References (45)

1. Nelson MI, Holmes EC (2007) The evolution of epidemic influenza. Nat Rev Genet 2007 8(3): 196-205.
2. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, et al. (2001) A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7(12): 1306-12.
3. Das K, Aramini JM, Ma LC, Krug RM, Arnold E (2010) Structures of influenza A proteins and insights into antiviral drug targets. Nat Struc Mol Biol 17(5): 530-8.
4. Fitch WM, Leiter JM, Li XQ, Palese P (1991) Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci USA 88(10): 4270-4274.
5. Fitch WM, Bush RM, Bender CA, Cox NJ (1997) Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci USA 94(15): 7712-7718.
6. Treanor J (2004) Influenza vaccine--outmaneuvering antigenic shift and drift. N Engl J Med 350(3): 218-220.
7. Nelson MI, Viboud C, Simonsen L, Bennett RT, Griesemer SB, et al. (2008) Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog 4(2): e1000012.
8. Holmes EC, Ghedin E, Miller N, Taylor J, Bao Y, et al. (2005) Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 3(9): e300.
9. Nelson MI, Edelman L, Spiro DJ, Boyne AR, Bera J, et al. (2008) Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog 4(8): e1000133.
10. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, et al. (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24(8): 1811-1820.
11. Furuse Y, Suzuki A, Kamigaki T, Shimizu M, Fuji N, et al. (2009) Reversion of influenza A (H3N2) virus from amantadine resistant to amantadine sensitive by further reassortment in Japan during the 2006-to-2007 influenza season. J Clin Microbiol 47(3): 841-844.
12. Deyde V, Garten R, Sheu T, Smith C, Myrick A, et al. (2009) Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008. Influenza Other Respi Viruses 3(6): 297-314.
13. Chen Z, Wang W, Zhou H, Suguitan AL, Jr., Shambaugh C, et al. (2010) Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 84(1): 44-51.
14. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360(25): 2605-2615.
15. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, et al. (2009) Triplereassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360(25): 2616-2625.
16. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325(5937): 197-201.
17. Centers for Disease Control and Prevention (CDC) (2009) Swine Influenza A (H1N1) Infection in Two Children---Southern California, March-April. MMWR Morb Mortal Wkly Rep 2009 58(15): 400-402.
18. Julkunen I, Pyhala R, Hovi T (1985) Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. J Virol Methods 10(1): 75-84.
19. Ruest A, Michaud S, Deslandes S, Frost EH (2003) Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 41(8): 3487-3493.
20. van Elden LJ, van Essen GA, Boucher CA, Van Loon AM, Nijhuis M, et al. (2001) Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract 51(469): 630-634.
21. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, Van Loon AM (2001) Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J Clin Microbiol 39(1): 196-200.
22. Wright KE, Wilson GA, Novosad D, Dimock C, Tan D, et al. (1995) Typing and subtyping of influenza viruses in clinical samples by PCR. J Clin Microbiol 33(5): 1180-1184.
23. Schweiger B, Zadow I, Heckler R, Timm H, Pauli G (2000) Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 38(4): 1552-1558.
24. World Health Organization (2002) Manual on Animal Influenza Diagnosis and Surveillance. WHO/CDS/CSR/NCS/2002.5.
25. Sampath R, Russell KL, Massire C, Eshoo MW, Harpin V, et al. (2007) Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS ONE 2(5): e489.
26. Khiabanian H, Trifonov V, Rabadan R (2009) Reassortment patterns in Swine influenza viruses. PLoS One 4(10): e736625.
27. Ecker DJ, Massire C, Blyn LB, Hofstadler SA, Hannis JC, et al. (2009) Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance. Methods Mol Biol 551: 71-87.
28. Sampath R, Hall TA, Massire C, Li F, Blyn LB, et al. (2007) Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci 1102: 109-120.
29. Faix DJ, Sherman SS, Waterman SH (2009) Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 361(7): 728-729.29.
30. Cheng PK, Leung TW, Ho EC, Leung PC, Ng AY, et al. (2009) Oseltamivirand amantadine-resistant influenza viruses A (H1N1). Emerg Infect Dis 15(6): 966-968.
31. Cheng PK, To AP, Leung TW, Leung PC, Lee CW, et al. (2010) Oseltamivirand amantadine-resistant influenza virus A (H1N1). Emerg Infect Dis 16(1): 155-156.
32. Sheu TG, Fry AM, Garten RJ, Deyde VM, Shwe T, et al. (2010) Dual Resistance to Adamantanes and Oseltamivir Among Seasonal Influenza A (H1N1) Viruses: 2008-2010. J Infec Dis. (In press).
33. Maynard A, Bloor K (2009) The economic impact of pandemic influenza. BMJ 339: b4888.
34. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, et al. (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459(7250): 1122-1125.
35. Stupar RM, Springer NM (2006) Cis-transcriptional variation in maize inbred lines B73 and Mo17 leads to additive expression patterns in the F-1 hybrid. Genetics 173: 2199-2210.
36. Ellegren H (2008) Sequencing goes 454 and takes large-scale genomics into the wild. Molecular Ecology 17: 1629-1631.
37. Hudson ME (2008) Sequencing breakthroughs for genomic ecology and evolutionary biology. Molecular Ecology Resources 8: 3-17.
38. Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current Protocols in Human Genetics 60: 2.12.11-12.12.18.
39. Buggs RJ, Chamala S, Wu W, Gao L, May GD, et al. (2010) Characterization of duplicate gene evolution in the recent natural allopolyploid Tragopogon miscellus by next-generation sequencing and Sequenom iPLEX MassARRAY genotyping. Mol Ecol Suppl 1: 132-46.
40. Shendure J, Porreca GJ, Reppas NB, Lin XX, McCutcheon JP, et al. (2005) Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309: 1728-1732.
41. Brownstein MJ, Carpten JD, Smith JR (1996) Modulation of non-templated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 20(6): 1004-1010.
42. Hofstadler SA, Sannes-Lowery KA, Hannis JC (2005) Analysis of nucleic acids by FTICR MS. Mass Spectrom Rev 24(2): 265-285.
43. Jiang Y, Hofstadler SA (2003) A highly efficient and automated method of purifying and desalting PCR products for analysis by electrospray ionization mass spectrometry. Anal Biochem 316(1): 50-57.
44. Hofstadler SA, Sampath R, Blyn LB, Eshoo MW, Hall TA, et al. (2005) TIGER: the universal biosensor. Inter J Mass Spectrom 242: 23-41.
45. Muddiman DC, Anderson GA, Hofstadler SA, Smith RD (1997) Length and base composition of PCR-amplified nucleic acids using mass measurements from electrospray ionization mass spectrometry. Anal Chem 69(8): 1543-1549.